Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

Roche - Basel

Roche to shut Applied Science unit

170 jobs in the firing line as pharma company reorganises diagnostic presence

- PMLiVE

Former Pfizer exec Stephen Williams joins Venaxis board

Is current chief medical officer of SomaLogic

- PMLiVE

NICE set to hand Bayer wider recommendation for Xarelto

Backs drug’s use to treat pulmonary embolism and prevent DVT

- PMLiVE

Charting a sea change in medical education

The medical education landscape has changed significantly over recent years. There are many reasons for this sea change, but two stand out...

- PMLiVE

FDA approves Alcon eye drug Simbrinza

Fixed-combination licensed to treat glaucoma patients in the US

- PMLiVE

Team Gold

Putting a best practice sharing model in place

- PMLiVE

Online social gaming campaign takes aim at cancer

EPAAC's I'm a Fan of Life initiative focuses on cancer prevention

- PMLiVE

EC gives green light to new 6-in-1 childhood vaccine from Sanofi, MSD

Hexyon/Hexacima protects against diphtheria, DTP, hepatitis B, polio, meningitis and Haemophilus influenzae type B

- PMLiVE

Lundbeck launches alcohol drug Selincro in Europe

Norway, Finland, Poland and the Baltic countries chosen as first markets

- PMLiVE

European drug applications ‘stable but more complex in 2012’

Despite austerity measures, EMA's annual report shows signs of biopharma resilience

- PMLiVE

AstraZeneca signs $200m deal with Bind for cancer drug

Follows deals with Amgen and Pfizer for Bind involving its Accurin nanotechnology

- PMLiVE

Roche faces another NICE rejection for Avastin

Draft guidance turns down drug for use in ovarian cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links